Data / Form D filings / Noetik Inc.
Noetik Inc.: Form D filings
Noetik Inc., a biotechnology company in South San Francisco, CA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on August 13, 2024, reports $40 million sold of a $40 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 TOWER PLACE, 17TH FLOOR, South San Francisco, CA, 94080
- Phone
- (650) 796-6619
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1944644
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2024 | New notice | $40,000,000 | $39,999,981 | $19 | 20 | Jul 31, 2024 | sec.gov |
| Sep 13, 2022 | New notice | $7,999,994 | $7,999,994 | 9 | Aug 30, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Hardiman | Director | |
| Jacob Rinaldi | Executive Officer, Director, Promoter | |
| Ronald Alfa | Executive Officer, Director, Promoter | |
| Amy Schulman | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 12, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Noetik Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.